Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for INRLF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Max Drawdown (5Y) Chart
Start Trial

Historical Max Drawdown (5Y) Data

View and export this data back to 2013. Start Trial.
Date Value
July 31, 2026 94.35%
June 30, 2026 94.35%
May 31, 2026 94.35%
April 30, 2026 94.35%
March 31, 2026 94.35%
February 28, 2026 94.35%
January 31, 2026 94.35%
December 31, 2025 94.35%
November 30, 2025 94.35%
October 31, 2025 94.35%
September 30, 2025 94.35%
August 31, 2025 94.35%
July 31, 2025 94.35%
June 30, 2025 94.35%
May 31, 2025 94.35%
April 30, 2025 94.35%
March 31, 2025 94.35%
February 28, 2025 94.35%
January 31, 2025 94.35%
December 31, 2024 94.35%
November 30, 2024 93.39%
October 31, 2024 91.80%
September 30, 2024 91.53%
August 31, 2024 89.94%
July 31, 2024 89.94%
Date Value
June 30, 2024 89.94%
May 31, 2024 89.94%
April 30, 2024 89.94%
March 31, 2024 89.94%
February 29, 2024 89.81%
January 31, 2024 87.99%
December 31, 2023 85.92%
November 30, 2023 85.92%
October 31, 2023 85.92%
September 30, 2023 85.92%
August 31, 2023 85.92%
July 31, 2023 85.92%
June 30, 2023 85.92%
May 31, 2023 85.92%
April 30, 2023 85.59%
March 31, 2023 85.47%
February 28, 2023 85.47%
January 31, 2023 85.47%
December 31, 2022 85.47%
November 30, 2022 85.47%
October 31, 2022 85.47%
September 30, 2022 85.47%
August 31, 2022 76.43%
July 31, 2022 76.43%
June 30, 2022 76.43%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Nicox SA 96.28%
DBV Technologies SA 98.19%
Cellectis SA 97.08%
Genfit SA 90.85%
Innate Pharma SA 85.56%